Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 3/20 | 0.51 |
| ▸ | DRD2 | P14416 | 2/20 | 0.51 |
| ▸ | HTR1A | P08908 | 1/20 | 0.51 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7497905 | 1.00 | HTR2A (0.51) | HTR2ADRD2HTR1ACHRNA7TSHR | |
| SCHEMBL7496035 | 0.87 | HTR2A (0.69) | HTR2ADRD2HTR1A | |
| SCHEMBL1383560 | 0.86 | MAPT (0.55) | — | |
| SCHEMBL1383563 | 0.86 | MAPT (0.55) | — | |
| SCHEMBL7489075 | 0.85 | ABCB1 (0.48) | HTR2ADRD2HTR1ACHRNA7PKM | |
| SCHEMBL5359817 | 0.85 | HTR2A (0.59) | HTR2ADRD2HTR1ACHRNA7TSHR | |
| SCHEMBL5364879 | 0.85 | HTR2A (0.59) | HTR2ADRD2HTR1ACHRNA7TSHR | |
| SCHEMBL1380843 | 0.85 | ABCB1 (0.48) | HTR2ADRD2HTR1ACHRNA7PKM | |
| SCHEMBL5359826 | 0.85 | HTR2A (0.59) | HTR2ADRD2HTR1ACHRNA7TSHR | |
| SCHEMBL1381988 | 0.84 | CHRNA7 (0.49) | HTR2ADRD2HTR1ACHRNA7TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1216244-A1 | Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as D4 antagonists | Aventis Pharmaceuticals Inc. (US) | 2002-06-26 | — | — | EP | disclosed |
| WO-2001019821-A1 | BENZISOXAZOLYL-, PYRIDOISOXAZOLYL- AND BENZTHIENYL-PHENOXY DERIVATIVES USEFUL AS D4 ANTAGONISTS | AVENTIS PHARMACEUTICALS INC. (US) | 2001-03-22 | — | — | WO | disclosed |